Compare · BIOS vs CONX
BIOS vs CONX
Side-by-side comparison of BioPlus Acquisition Corp. (BIOS) and CONX Corp. (CONX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIOS and CONX operate in Blank Checks (Finance), so they compete in similar markets.
- CONX carries a market cap of $919.0M.
BioPlus Acquisition Corp.
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
CONX Corp.
CONX Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or assets. It intends to focus its search on identifying a prospective target operating in the technology, media, and telecommunications industries, including the wireless communications industry. The company was incorporated in 2020 and is based in Littleton, Colorado.
Latest BIOS
- ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form 15-12G filed by BioPlus Acquisition Corp.
- SEC Form 25-NSE filed by BioPlus Acquisition Corp.
- SEC Form RW filed by BioPlus Acquisition Corp.
- Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
- BioPlus Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Latest CONX
- SEC Form 10-Q filed by CONX Corp.
- SEC Form SC 13D filed by CONX Corp.
- SEC Form SC 13D filed by CONX Corp.
- CONX Corp. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
- Ergen Charles W converted options into 18,750,000 shares (SEC Form 4)
- SEC Form 3 filed by new insider Gst-Exempt Ranch Legacy Trust
- CONX Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- CONX Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Regulation FD Disclosure, Financial Statements and Exhibits
- CONX Corp. Announces Closing of Initial Business Combination
- SEC Form SC 13G/A filed by CONX Corp. (Amendment)